Literature DB >> 23616276

A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.

Benedetta Bodini1, Mara Cercignani, Ahmed Toosy, Nicola De Stefano, David H Miller, Alan J Thompson, Olga Ciccarelli.   

Abstract

We combined tract-based spatial statistics (TBSS) and magnetization transfer (MT) imaging to assess white matter (WM) tract-specific short-term changes in early primary-progressive multiple sclerosis (PPMS) and their relationships with clinical progression. Twenty-one PPMS patients within 5 years from onset underwent MT and diffusion tensor imaging (DTI) at baseline and after 12 months. Patients' disability was assessed. DTI data were processed to compute fractional anisotropy (FA) and to generate a common WM "skeleton," which represents the tracts that are "common" to all subjects using TBSS. The MT ratio (MTR) was computed from MT data and co-registered with the DTI. The skeletonization procedure derived for FA was applied to each subject's MTR image to obtain a "skeletonised" MTR map for every subject. Permutation tests were used to assess (i) changes in FA, principal diffusivities, and MTR over the follow-up, and (ii) associations between changes in imaging parameters and changes in disability. Patients showed significant decreases in MTR over one year in the corpus callosum (CC), bilateral corticospinal tract (CST), thalamic radiations, and superior and inferior longitudinal fasciculi. These changes were located both within lesions and the normal-appearing WM. No significant longitudinal change in skeletonised FA was found, but radial diffusivity (RD) significantly increased in several regions, including the CST bilaterally and the right inferior longitudinal fasciculus. MTR decreases, RD increases, and axial diffusivity decreases in the CC and CST correlated with a deterioration in the upper limb function. We detected tract-specific multimodal imaging changes that reflect the accrual of microstructural damage and possibly contribute to clinical impairment in PPMS. We propose a novel methodology that can be extended to other diseases to map cross-subject and tract-specific changes in MTR.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  magnetization transfer imaging; primary-progressive multiple sclerosis; tract-based spatial statistics

Mesh:

Year:  2013        PMID: 23616276      PMCID: PMC6869406          DOI: 10.1002/hbm.22196

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  65 in total

1.  A magnetization transfer histogram study of normal-appearing brain tissue in MS.

Authors:  C Tortorella; B Viti; M Bozzali; M P Sormani; G Rizzo; M F Gilardi; G Comi; M Filippi
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

2.  A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  E Pagani; M Filippi; M A Rocca; M A Horsfield
Journal:  Neuroimage       Date:  2005-02-25       Impact factor: 6.556

3.  Quantitative characterization of the corticospinal tract at 3T.

Authors:  D S Reich; S A Smith; C K Jones; K M Zackowski; P C van Zijl; P A Calabresi; S Mori
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 4.  Clinical outcome measures and rating scales in multiple sclerosis trials.

Authors:  D M Wingerchuk; J H Noseworthy; B G Weinshenker
Journal:  Mayo Clin Proc       Date:  1997-11       Impact factor: 7.616

5.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Authors:  G R Cutter; M L Baier; R A Rudick; D L Cookfair; J S Fischer; J Petkau; K Syndulko; B G Weinshenker; J P Antel; C Confavreux; G W Ellison; F Lublin; A E Miller; S M Rao; S Reingold; A Thompson; E Willoughby
Journal:  Brain       Date:  1999-05       Impact factor: 13.501

6.  Decreased frontostriatal microstructural organization in attention deficit/hyperactivity disorder.

Authors:  Patrick de Zeeuw; René C W Mandl; Hilleke E Hulshoff Pol; Herman van Engeland; Sarah Durston
Journal:  Hum Brain Mapp       Date:  2011-08-08       Impact factor: 5.038

7.  In vivo evaluation of remyelination in rat brain by magnetization transfer imaging.

Authors:  M S Deloire-Grassin; B Brochet; B Quesson; C Delalande; V Dousset; P Canioni; K G Petry
Journal:  J Neurol Sci       Date:  2000-09-01       Impact factor: 3.181

8.  Grey and white matter changes at different stages of Alzheimer's disease.

Authors:  Laura Serra; Mara Cercignani; Delia Lenzi; Roberta Perri; Lucia Fadda; Carlo Caltagirone; Emiliano Macaluso; Marco Bozzali
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

Authors:  J H van Waesberghe; W Kamphorst; C J De Groot; M A van Walderveen; J A Castelijns; R Ravid; G J Lycklama à Nijeholt; P van der Valk; C H Polman; A J Thompson; F Barkhof
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

10.  Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain.

Authors:  Klaus Schmierer; Francesco Scaravilli; Daniel R Altmann; Gareth J Barker; David H Miller
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

View more
  7 in total

1.  Neural correlates of symptom severity in obsessive-compulsive disorder using magnetization transfer and diffusion tensor imaging.

Authors:  Suzan Maleki; Yann Chye; Xiaoliu Zhang; Linden Parkes; Samuel R Chamberlain; Leonardo F Fontenelle; Leah Braganza; George Youssef; Valentina Lorenzetti; Ben J Harrison; Murat Yücel; Chao Suo
Journal:  Psychiatry Res Neuroimaging       Date:  2020-02-11       Impact factor: 2.376

2.  Magnetization transfer in lamellar liquid crystals.

Authors:  Dariya I Malyarenko; Ellen M Zimmermann; Jeremy Adler; Scott D Swanson
Journal:  Magn Reson Med       Date:  2013-11-20       Impact factor: 4.668

3.  Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.

Authors:  Khaled Abdel-Aziz; Torben Schneider; Bhavana S Solanky; Marios C Yiannakas; Dan R Altmann; Claudia A M Wheeler-Kingshott; Amy L Peters; Brian L Day; Alan J Thompson; Olga Ciccarelli
Journal:  Brain       Date:  2015-04-10       Impact factor: 13.501

4.  Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.

Authors:  Cristina Granziera; Jens Wuerfel; Frederik Barkhof; Massimiliano Calabrese; Nicola De Stefano; Christian Enzinger; Nikos Evangelou; Massimo Filippi; Jeroen J G Geurts; Daniel S Reich; Maria A Rocca; Stefan Ropele; Àlex Rovira; Pascal Sati; Ahmed T Toosy; Hugo Vrenken; Claudia A M Gandini Wheeler-Kingshott; Ludwig Kappos
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

5.  An in vivo study on brain microstructure in biological and chronological ageing.

Authors:  Irmhild Altmann-Schneider; Anton J M de Craen; Annette A van den Berg-Huysmans; Pieternella Slagboom; Rudi G J Westendorp; Mark A van Buchem; Jeroen van der Grond
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

6.  A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.

Authors:  Ece Ercan; Carson Ingo; Oranan Tritanon; Cesar Magro-Checa; Alex Smith; Seth Smith; Tom Huizinga; Mark A van Buchem; Itamar Ronen
Journal:  Neuroimage Clin       Date:  2015-05-16       Impact factor: 4.881

7.  The Combined Quantification and Interpretation of Multiple Quantitative Magnetic Resonance Imaging Metrics Enlightens Longitudinal Changes Compatible with Brain Repair in Relapsing-Remitting Multiple Sclerosis Patients.

Authors:  Guillaume Bonnier; Benedicte Maréchal; Mário João Fartaria; Pavel Falkowskiy; José P Marques; Samanta Simioni; Myriam Schluep; Renaud Du Pasquier; Jean-Philippe Thiran; Gunnar Krueger; Cristina Granziera
Journal:  Front Neurol       Date:  2017-09-27       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.